Results 111 to 120 of about 59,240 (301)

Crafting the Future: Developing Graduate Programs Aligned With Demographic Trends

open access: yesNew Directions for Teaching and Learning, EarlyView.
ABSTRACT In response to changing student demographics and increasing budget constraints, many colleges and universities are reevaluating their graduate education strategies. While some institutions are striving to save costs via program cuts and layoffs, others are refocusing attention on student recruitment, specifically targeting working adults as a ...
Jennifer A. Owens   +2 more
wiley   +1 more source

Should Cannabis as Medicine be Specifically Regulated?

open access: yesPharmacology and Clinical Pharmacy Research, 2018
In 2017, a patient case in Sangau, West Kalimantan, involving a women with syringomyelia has drawn public attention. The case ended with the arrest of her husband who cultivated Cannabis to treat her disease.
Gunawan Widjaja
doaj  

HSE will reimburse cost of Ava Twomey’s medical cannabis. [PDF]

open access: yes, 2018
....Mr Harris previously said the legal issues involved in developing a reimbursement process for cannabis-based products for medicinal use were being examined.
McMahon, Aine
core  

State cannabis laws and cannabis positivity among fatally injured drivers [PDF]

open access: yes
Background As of November 8, 2023, 24 states and the District of Columbia have legalized cannabis for both recreational and medical use (RMCL-states), 14 states have legalized cannabis for medical use only (MCL-states) and 12 states have ...
Li, Guohua   +2 more
core   +2 more sources

Impacts of Global Cannabis Policy Changes on Substance Use: A Systematic Review of Quasi‐Experimental Studies

open access: yesThe Milbank Quarterly, EarlyView.
Policy Points The liberalization of medical and recreational cannabis policies may increase cannabis initiation across age groups, with increased prevalence of cannabis use among young adults and adults and weaker effects among youth. Evidence also suggests increases in cannabis‐related health care utilization among adults.
SARAH B. WINDLE   +8 more
wiley   +1 more source

Medical Cannabis

open access: yesAnnals of Emergency Medicine, 2019
Jørgen G, Bramness, Vigdis, Vindenes
  +6 more sources

Medical cannabis - the Canadian perspective.

open access: yesJournal of pain research, 2016
Cannabis has been widely used as a medicinal agent in Eastern medicine with earliest evidence in ancient Chinese practice dating back to 2700 BC. Over time, the use of medical cannabis has been increasingly adopted by Western medicine and is thus a rapidly emerging field that all pain physicians need to be aware of. Several randomized controlled trials
Ko, Gordon D   +3 more
openaire   +2 more sources

Minister for Health to assist patients with access to prescribed medical cannabis products. [PDF]

open access: yes, 2020
The Minister for Health Stephen Donnelly has today announced that patients who are prescribed medical cannabis products will no longer need to travel to the Netherlands to collect their medication.

core  

Evaluation of illicit drug contaminants in seized cannabis in Arizona and California, 2023–2024

open access: yesJournal of Forensic Sciences, EarlyView.
Abstract Despite public health concerns, fentanyl, cocaine, and other illicit drug contaminants remain largely understudied in unregulated cannabis. Here, we developed an analytical method to quantify a panel of common illicit drugs in cannabis and tested the law enforcement seizures in Arizona and California in evaluation of the illicit drug ...
Beckner Andersano   +3 more
wiley   +1 more source

Prevalence of novel psychoactive substances in selected clinical urine specimens submitted for drug monitoring

open access: yesJournal of Forensic Sciences, EarlyView.
Abstract Novel psychoactive substances (NPS) are compounds emerging as alternatives to more established drugs of abuse. They are constantly changing and being modified, which makes their detection difficult. The study objective was to determine the prevalence of NPS in selected clinical specimens. Deidentified urine specimen remnants were analyzed that
Jillian R. Neifeld   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy